Sort   by:  
 Page size 
ProteomicsDiscovery of efficacy biomarkers for NSCLC with first-line anti-PD-1 immunotherapy by DIA
To discover potential plasma biomarkers, we are aiming to explore circulating and tumor-derived proteins related to the efficacy of anti-PD-1 treatment to select the optimal NSCLC patients for immunotherapy via DIA.
ORGANISM(S): Homo Sapiens 
2022-02-07 | PXD031474 |
ProteomicsUrinary proteomics identifying novel biomarkers for the diagnosis and phenotyping of carotid artery stenosis
We used the data-independent acquisition (DIA) technique to conduct a urinary proteomic study in patients with CAS and healthy controls.
ORGANISM(S): Homo Sapiens 
2021-06-04 | PXD026501 |
Sort   by:  
 Page size